Allocation of Bamlanivimab by Jurisdiction

Bamlanivimab is allocated by the federal government to states, territories, and federal entities on a weekly basis. Bamlanivimab Allocation Table is current through March 2, 2021.

Distribution Weeks:

Distribution Cycle 1 - Week 1: November 9-17, 2020
Distribution Cycle 2 - Week 2: November 18-23, 2020
Distribution Cycle 3 - Week 3: November 24 - December 1, 2020
Distribution Cycle 4 - Week 4: December 2-8, 2020
Distribution Cycle 5 - Week 5: December 9-15, 2020
Distribution Cycle 6 - Week 6: December 16-22, 2020
Distribution Cycle 7 - Weeks 7-8: December 22, 2020 - January 5, 2021
Distribution Cycle 9 - Weeks 9-10: January 6-19, 2021
Distribution Cycle 10 - Weeks 11-12: January 19-February 2, 2021
Distribution Cycle 11 - Weeks 13-14: February 3-16, 2021
Distribution Cycle 12 - Weeks 15-16: February 17- March 2, 2021

States / Territories / Federal Entities	Wk 1 Phase 1 (patient courses)	Wk 2 Phase 1 (patient courses)	Wk 3 Phase 2 (patient courses)	Wk 4 Phase 2 (patient courses)	Wk 5 Phase 2 (patient courses)	Wk 6 Phase 2 (patient courses)	Wks 7-8 Phase 2 (patient courses)	Wks 9-10 Phase 2 (patient courses)	Wks 11-12 Phase 2 (patient courses)	Wks 13-14 Phase 2 (patient courses)	Wks 15-16 Phase 2 (patient courses)	Total Patient Courses Allocated
Alabama	1,080	500	610	580	660	760	2,020	4,670	5,000	2,450	890	19,220
Alaska	240	120	120	130	120	120	60	110	150	60	40	12,70
American Samoa	10	0	0	0	0	0	0	0	10	0	0	20
Arizona	1,250	630	970	970	1,230	1,670	2,940	3,220	4,310	2,780	1,420	21,390
Arkansas	950	450	530	460	470	500	1,020	2,560	1,300	890	530	9,660
Bureau of Prisons	100	0	0	0	0	0	0	0	0	100	70	270
California	4,040	2,250	3,230	3,790	4,450	6,420	14,124	14,534	18,050	10,250	5,310	86,448
Colorado	1,980	1,080	1,320	1,130	960	960	500	480	730	730	590	10,460
Commonwealth of the Northern Mariana Islands	10	0	10	0	10	10	10	0	0	0	0	50
Connecticut	600	420	510	430	530	570	970	800	1,370	820	570	7,590
Delaware	140	90	120	140	170	290	420	290	400	260	190	2,510
Department of Defense	300	200	200	300	0	0	200	200	100	300	0	200
Department of Health and Human Services	0	0	200	0	0	0	0	0	0	0	300	2,100
Department of State	50	0	0	200	0	0	0	0	400	0	0	650
District of Columbia	90	50	60	90	70	80	225	325	220	160	110	1,480
Federated States of Micronesia	10	0	0	0	0	0	0	0	0	0	0	10
Florida	3,890	1,730	2,230	2,150	2,140	2,370	5065	5,590	7,400	5,260	4,240	42,065
Georgia	1,920	860	1,010	940	1,100	1,440	3,000	3,880	4,640	3,600	2,210	24,600
Guam	50	100	50	20	10	10	10	10	30	10	0	300
Hawaii	80	30	40	60	30	30	60	60	100	30	30	550
Idaho	680	290	330	330	280	290	500	510	590	210	100	4,110
Illinois	6,380	2,930	3,160	2,340	2,080	2,080	3,730	3,310	3,320	1,920	1,240	32,490
Indiana	2,750	1,480	1,700	1,470	1,410	1,410	2,490	3,600	2,340	1,230	1,200	9,200
Indian Health Service	300	300	200	300	0	700	1,400	1,400	1,400	2,000	770	20,650
Iowa	2,110	1,030	1,030	680	510	510	747	847	800	430	320	9,014
Kansas	1,330	700	780	630	580	580	1910	1,780	1,860	600	360	11,110
Kentucky	1,980	920	1,140	1,030	1,010	1,220	2,170	1,800	1,850	1,850	1,290	16,260
Louisiana	690	540	620	530	620	620	3,444	6,051	2,156	1,190	650	17,111
Maine	90	50	60	60	70	80	170	170	360	140	90	1,340
Maryland	840	520	710	700	690	690	1,210	1,180	1,560	1,130	710	9,940
Massachusetts	1,020	560	670	600	870	1,010	1,870	1,600	1,920	100	300	10,520
Michigan	3,240	1,740	2,090	1,970	1,580	1,580	2,810	2,710	3,080	1,130	680	22,610
Minnesota	2,400	1,400	1,580	1,310	990	990	1,590	1,460	2,460	570	380	15,130
Mississippi	660	330	420	410	430	910	3,060	4,329	1,910	740	420	13,619
Missouri	2,440	1,230	1,410	1,070	900	900	1,620	1,380	1,380	910	550	13,790
Montana	710	310	370	260	210	210	290	190	280	180	130	3,140
National Institute of Health	0	50	0	0	0	0	0	0	0	0	0	50
Nebraska	1,170	570	630	490	480	480	940	940	1,110	230	210	7,250
Nevada	800	470	590	600	590	630	1,340	880	1,040	680	430	8,050
New Hampshire	100	70	100	130	150	180	310	310	430	210	150	2,140
New Jersey	1,550	980	1,200	1,190	1,200	1,300	2,550	2,040	3,320	2,510	1,210	19,050
New Mexico	750	340	590	420	370	370	590	490	610	380	100	5,010
New York	2,140	1,350	1,670	1,940	2,210	2,430	5,850	5,660	8,350	5,160	4,610	41,370
North Carolina	1,690	740	970	930	1,030	1,270	2,520	2,670	4,065	2,670	1,430	19,985
North Dakota	770	290	320	200	180	190	150	110	130	70	50	2460
Ohio	3,420	1,900	2,330	2,330	2,150	2,690	4,930	4,130	4,160	2,440	1,580	32,060
Oklahoma	1,230	770	940	910	770	790	1,650	3,687	1,910	1,370	800	14,827
Oregon	430	230	300	340	300	300	520	420	630	340	130	3,940
Palau	10	0	0	0	0	0	0	0	10	0	0	20
Pennsylvania	2,300	1,380	1,870	1,980	2,180	2,990	5,120	4,920	4,920	2,980	1,880	32,520
Puerto Rico	640	180	200	170	150	150	340	200	390	160	100	2,680
Republic of Marshall Islands	10	0	0	0	0	0	0	0	0	0	0	10
Rhode Island	310	160	210	190	220	220	370	474	540	710	170	3,574
South Carolina	800	360	410	390	510	600	1,832	3,560	2,350	1,701	1,340	13,853
South Dakota	820	340	340	240	230	230	460	430	510	90	70	3,760
Tennessee	1,900	1,080	1,170	1,130	1,100	1,560	3,450	2,790	2,500	1,340	650	18,670
Texas	5,780	3,190	3,840	3,260	3,160	4,805	8,130	9,932	12,660	8,480	5,750	68,987
U.S. Virgin Islands	10	10	10	10	10	10	10	10	20	10	10	120
Utah	1,300	600	750	510	540	540	890	760	900	640	170	7,600
Vermont	20	20	30	20	30	40	100	40	100	70	40	510
Veterans Health Administration	300	0	200	300	0	0	200	200	600	400	400	2,600
Virginia	1,010	430	620	640	650	820	1,570	1,750	3,170	2,040	1,470	14,170
Washington	720	410	430	570	510	530	720	770	1,480	740	70	6,950
West Virginia	370	100	260	270	260	280	580	848	800	430	240	4,438
Wisconsin	4,260	1,860	1,990	1,380	1,110	1,110	2,190	2,010	1,970	950	560	19,390
Wyoming	330	160	200	140	110	110	160	110	220	80	50	1670
All Jurisdictions (patient courses)	79,350	40,980	49,550	45,760	44,380	53,635	107,107	119,187	130,371	78,911	49,360	798,591

Current Total Monoclonal Antibody Therapeutics Allocated and Delivered

Therapeutic	Total Allocation (patient courses)	Total Delivered (patient courses)
Bamlanivimab (through March 2, 2021)	798,591	664,691
Casirivimab/imdevimab (through February 2, 2021)	148,022	96,923
All Monoclonal Antibody Therapeutics	946,613	761,614

Allocation Phases

Phase 1: allocation to hospitals and hospital-affiliated locations
Phase 2: allocation expanded to additional outpatients facilities

Related Resources

This page last reviewed: April 16, 2021